Newcastle disease chimeric virus marker vaccine strain as well as construction method and application thereof
A technology for Newcastle disease virus and chimeric virus, applied in the field of Newcastle disease chimeric virus marker vaccine strain and its construction, can solve the problems of limited protective power and no protection of epidemic strains, and achieve high reproductive titer and good immunogenicity. , the effect of excellent growth characteristics
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Construction of full-length cDNA clone of recombinant viral genome
[0033] The main experimental material medium is MEM medium containing 10% fetal bovine serum, NDV vaccine strain La Sota was purchased from China Veterinary Drug Administration, BHK-21 cells were purchased from ATCC, SPF chicken embryos and SPF chicken were purchased from Boehringerville Provided by the Experimental Animal Center.
[0034] Main reagents Plasmid extraction kit and gel recovery kit were purchased from Tiangen Company; restriction endonuclease and T4 DNA ligase were purchased from NEB Company; virus RNA extraction kit was purchased from Tiangen Company; E.coli DH5α competent cells Purchased from the whole gold biology; pMDl8-T Vector and GXL DNA Polymerase was purchased from TaKaRa; Lipofectamine TM 2000 transfection reagent was purchased from Invitrogen.
[0035] 1. Primer design and synthesis According to the synthetic sequence of chicken Newcastle disease gene type VII and the sequ...
Embodiment 2
[0050] Construction of helper plasmids
[0051] According to the full-length genome sequence of La Sota strain, primers were designed to amplify the open reading frames (ORFs) encoding nucleoprotein NP, phosphoprotein P and polymerase protein L, respectively. The primers are shown in Table 3. The three ORFs were respectively cloned into the downstream of the CMV promoter of the eukaryotic expression vector pCI-neo. The constructed helper plasmids were named pCI-NP, pCI-P and pCI-L, respectively.
[0052] The construction primer sequence of table 3 auxiliary plasmid
[0053]
[0054] Note: The underlined part is the restriction site.
Embodiment 3
[0056] Construction of BHK T7 cells expressing T7 RNA polymerase
[0057] (1) Synthesize the sequence based on the T7 RNA polymerase sequence (SEQ ID: FJ881694.1) recorded on the NCBI official website to construct the PMV-T7 RNA polymerase plasmid; (2) Ligate the PMV-T7 RNA polymerase plasmid with the P1020 vector overnight, The ligation product was transformed into DH5α competent cells, and the P1020-T7 RNA polymerase positive plasmid was screened out by PCR identification and sequencing identification; (3) The recombinantly constructed P1020-T7 RNA polymerase plasmid was used in the plasmid extraction kit of Tiangen Biochemical Technology Co., Ltd. Extract the plasmid and perform follow-up experiments after confirmation; (4) Transfect the plasmid into cultured BHK-21 adherent cells based on electroporation; Cultivate the cell line, and complete the screening process of the cell line; (6) amplify the screened cell line, and use WB detection to screen the positive cell line wi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com